| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.66B | +49.6% |
| Cost of Revenue | $253.0M | +16.0% |
| R&D Expense | $270.8M | -31.2% |
| SG&A Expense | $689.8M | +13.9% |
| Operating Income | $414.1M | +391.1% |
| Interest Expense | $23.0M | +76.6% |
| Pre-tax Income | $421.5M | +351.9% |
| Income Tax | -$97.6M | -980.4% |
| Net Income | $355.8M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $457.5M | +56.4% |
| Accounts Receivable | $332.5M | +15.5% |
| Inventory | $186.4M | +2.7% |
| Current Assets | $1.49B | +31.4% |
| Total Assets | $2.14B | +8.8% |
| Current Liabilities | $520.2M | +4.5% |
| Long-term Debt | $287.7M | -0.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $401.4M | +1807.2% |
| Capital Expenditures | $48.0M | +25.6% |
| Investing Cash Flow | $53.4M | +182.7% |
| Financing Cash Flow | -$289.7M | — |
| Free Cash Flow | $353.3M | +2152.8% |
| +324.8% |
| EPS (Basic) | $2.14 | +320.6% |
| EPS (Diluted) | $2.10 | +316.5% |
| Total Liabilities |
| $933.5M |
| +1.4% |
| Stockholders' Equity | $1.20B | +15.2% |